STOCK TITAN

AMGEN ANNOUNCES WEBCAST OF 2025 FIRST QUARTER FINANCIAL RESULTS

Rhea-AI Impact
(Low)
Rhea-AI Sentiment
(Neutral)
Tags

Amgen (NASDAQ: AMGN) has scheduled its first quarter 2025 financial results announcement for Thursday, May 1, 2025, after market close. The company will host a conference call with the investment community at 4:30 p.m. ET.

Key highlights:

  • Leadership Participation: Robert A. Bradway, chairman and chief executive officer, along with other senior management team members will lead the discussion
  • Public Access: The event will be accessible to news media, investors, and the general public
  • Webcast Details: Live audio will be streamed on www.amgen.com under the Investors section
  • Replay Availability: The webcast recording will remain accessible for at least 90 days after the event

Interested parties can find additional information about presentation times and webcast links on Amgen's Investor Relations Events Calendar on their website.

Loading...
Loading translation...

Positive

  • Senior management team including CEO Robert A. Bradway will participate in the earnings call, showing high-level engagement with investors
  • Extended 90-day webcast archive availability ensures transparency and accessibility for investors

Negative

  • None.

News Market Reaction 1 Alert

+1.93% News Effect

On the day this news was published, AMGN gained 1.93%, reflecting a mild positive market reaction.

Data tracked by StockTitan Argus on the day of publication.

THOUSAND OAKS, Calif., April 28, 2025 /PRNewswire/ -- Amgen (NASDAQ:AMGN) today announced that it will report its first quarter 2025 financial results on Thursday, May 1, 2025, after the close of the U.S. financial markets. The announcement will be followed by a conference call with the investment community at 4:30 p.m. ET. Participating in the call from Amgen will be Robert A. Bradway, chairman and chief executive officer, and other members of Amgen's senior management team.

Live audio of the conference call will be simultaneously broadcast over the internet and will be available to members of the news media, investors and the general public.

The webcast, as with other selected presentations regarding developments in Amgen's business given by management at certain investor and medical conferences, can be found on Amgen's website, www.amgen.com, under Investors. Information regarding presentation times, webcast availability and webcast links are noted on Amgen's Investor Relations Events Calendar. The webcast will be archived and available for replay for at least 90 days after the event.

About Amgen

Amgen discovers, develops, manufactures and delivers innovative medicines to help millions of patients in their fight against some of the world's toughest diseases. More than 40 years ago, Amgen helped to establish the biotechnology industry and remains on the cutting-edge of innovation, using technology and human genetic data to push beyond what's known today. Amgen is advancing a broad and deep pipeline that builds on its existing portfolio of medicines to treat cancer, heart disease, osteoporosis, inflammatory diseases and rare diseases. 

In 2024, Amgen was named one of the "World's Most Innovative Companies" by Fast Company and one of "America's Best Large Employers" by Forbes, among other external recognitions. Amgen is one of the 30 companies that comprise the Dow Jones Industrial Average®, and it is also part of the Nasdaq-100 Index®, which includes the largest and most innovative non-financial companies listed on the Nasdaq Stock Market based on market capitalization. 

For more information, visit Amgen.com and follow us on X (formerly known as Twitter), LinkedIn, Instagram, TikTok, YouTube and Threads

CONTACT: Amgen, Thousand Oaks
Elissa Snook, 609-251-1407 (media) 
Justin Claeys, 805-313-9775 (investors)

Amgen Logo. (PRNewsFoto/Amgen) (PRNewsFoto/)

Cision View original content to download multimedia:https://www.prnewswire.com/news-releases/amgen-announces-webcast-of-2025-first-quarter-financial-results-302439826.html

SOURCE Amgen

FAQ

When will Amgen (AMGN) release Q1 2025 earnings?

Amgen will release its first quarter 2025 financial results on Thursday, May 1, 2025, after the U.S. financial markets close.

What time is Amgen's Q1 2025 earnings call on May 1?

Amgen's Q1 2025 earnings conference call is scheduled for 4:30 p.m. ET on May 1, 2025.

How can I listen to Amgen's (AMGN) Q1 2025 earnings webcast?

The earnings webcast can be accessed on Amgen's website at www.amgen.com under the Investors section. The webcast will be available for replay for at least 90 days after the event.

Who will participate in Amgen's Q1 2025 earnings call?

Robert A. Bradway, chairman and chief executive officer, along with other members of Amgen's senior management team will participate in the earnings call.

Where can investors find Amgen's upcoming investor presentations schedule?

Investors can find information about upcoming presentations and webcast links on Amgen's Investor Relations Events Calendar at www.amgen.com under Investors.
Amgen Inc

NASDAQ:AMGN

AMGN Rankings

AMGN Latest News

AMGN Latest SEC Filings

AMGN Stock Data

176.25B
537.30M
0.21%
84.13%
2.19%
Drug Manufacturers - General
Biological Products, (no Disgnostic Substances)
Link
United States
THOUSAND OAKS